Supplementary Information for Broad protection against Invasive fungal disease from a nanobody targeting the active site of fungal β-1,3-glucanosyltransferases [Dataset]
IISA and CSIC adhere to all protocols set by the Committee of Animal Experimentation of the University of Zaragoza, accredited as the Body in Charge of Animal Welfare (OEBA). All experimental procedures comply with FELASA guidelines. In handling animals, we follow the 4Rs rule (Reduction, Refinement...
| Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | conjunto de datos |
| Publication Date: | 2024 |
| Country: | España |
| Institution: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repository: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/365945 |
| Online Access: | http://hdl.handle.net/10261/365945 |
| Access Level: | Open access |
| Keyword: | Nanobodies Fungal cell wall Aspergillus fumigatus Cryptococcus Immunotherapy Glucanosyltransferases Transglycosylases http://metadata.un.org/sdg/3 Ensure healthy lives and promote well-being for all at all ages Cryptococcus (fungi) Cryptococcus neoformans immunotherapy |
| Summary: | IISA and CSIC adhere to all protocols set by the Committee of Animal Experimentation of the University of Zaragoza, accredited as the Body in Charge of Animal Welfare (OEBA). All experimental procedures comply with FELASA guidelines. In handling animals, we follow the 4Rs rule (Reduction, Refinement, Replacement, and Responsibility) as mandated by Royal Decree 53/2013, dated February 1. The degree of animal suffering and/or pain is monitored using the Morton and Griffiths scales, and appropriate measures, such as analgesia or euthanasia, are administered as necessary. Permissions for these procedures were granted under PI33/20 and PI44/20.-- Under a Creative Commons.license BY 4.0. |
|---|